The role of the National Polio Laboratory and the network of Sub-National Laboratories in the eradication of poliomyelitis in Spain

e202503016

Authors

  • María Cabrerizo Laboratorio Nacional de Polio-Laboratorio de Enterovirus y Virus productores de Gastroenteritis; Centro Nacional de Microbiología; Instituto de Salud Carlos III. Madrid. España. / CIBER de epidemiología y salud pública. Madrid. España. https://orcid.org/0000-0001-7054-5696
  • María Dolores Fernández-García Laboratorio Nacional de Polio-Laboratorio de Enterovirus y Virus productores de Gastroenteritis; Centro Nacional de Microbiología; Instituto de Salud Carlos III. Madrid. España. / CIBER de epidemiología y salud pública. Madrid. España. https://orcid.org/0000-0003-0336-6596

Keywords:

poliovirus, enterovirus, parálisis flácida aguda, cultivo celular, genotipado

Abstract

The aim of this paper was to describe the activities carried out by the National Poliovirus Laboratory (LNP) and the Spanish Acute Flaccid Paralysis (AFP) Surveillance Network. The LNP coordinates the network since 1998 and is responsible for the characterization of polioviruses (PV) and other enteroviruses (EV) detected, using cell culture and molecular methods. It is annually accredited by WHO and represents Spain in the World Health Organization European Polio Laboratory Network. In addition to the reported AFP cases, the network has analyzed since its creation an average of 9,000 clinical samples annually for EV, with a 7% of positive results. Two surveillance periods can be distinguished in Spain: from 1998 to 2004, when vaccine PV could be detected due to the use of the oral polio vaccine, and from 2005 onwards, when only three cases of imported vaccine-derived PV have been identified following the introduction of the inactivated polio vaccine. In addition, between 70% and 85% of the EV samples received at the LNP are successfully genotyped. The work carried out by the lab network has contributed to the epidemiological and clinical surveillance and research of these infections, as well as to the rapid detection and characterization of imported poliomyelitis cases. This has facilitated the timely implementation of appropriate measures to prevent PV transmission and circulation in our country, in alignment with the Global Polio Eradication Initiative.

Downloads

Download data is not yet available.

References

Kew OM, Sutter RW, De Gourville EM, Dowdle WR, Pallansch MA. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annual Review of Microbiology. 2005. 59:587-635.

WHO. Poliomyelitis: Key Facts. Disponible en: https://www.who.int/news-room/fact-sheets/detail/poliomyelitis

Kew O, Pallansch M. Breaking the Last Chains of Poliovirus Transmission: Progress and Challenges in Global Polio Eradication. Annu Rev Virol [Internet]. 2018 Sep 29 [consultado 2 dic 2024];5(1):427-451.

Global Polio Eradication Initiative: https://polioeradication.org/

Polio Global Eradication Initiative. Polio Affected Countries. Último acceso enero 2025. Disponible en: https://polioeradication.org/about-polio/where-we-work/

Classification and reporting of vaccine-derived polioviruses. GPEI guidelines. Agosto 2016. Disponible en: https://polioeradication.org/wp-content/uploads/2016/09/Reporting-and-Classification-of-VDPVs_Aug2016_EN.pdf

World Health Organization (WHO). Polio vaccines: WHO position paper–June 2022. Weekly Epidemiol Report, 2022, 97, 277–300. 2022. Disponible en: https://www.who.int/publications-detail-redirect/WHO-WER9725-277-300

Laboratory support for poliomyelitis eradication: memorandum from a WHO meeting-PubMed [Internet]. [consultado 13 dic 2024]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/2572355/

Plan de acción en España para la erradicación de la poliomielitis 2024-2028 (julio 2024). Consejo Interterritorial del Sistema Nacional de Salud. Ministerio de Sanidad. Disponible en: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/polio

Polio Laboratory Manual. World Health Organization. 4th edition 2004. Disponible en: https://polioeradication.org/wp-content/uploads/2017/05/Polio_Lab_Manual04.pdf

WHO/CDC Guidelines for enterovirus surveillance in support of the Polio Eradication Initiative. Disponible en: https://stacks.cdc.gov/pdfjs/web/viewer.html?file=https://stacks.cdc.gov/view/cdc/82809/cdc_82809_DS1.pdf

Cartera de servicios para el diagnóstico microbiológico y/o referencia del Centro Nacional de Microbiología. Disponible en: https://www.boe.es/eli/es/res/2023/11/14/(5)/dof/spa/pdf

Cabrerizo M, Fernandez-García MD, Otero A, Higueras P. Programa de Enterovirus y Parálisis Flácida en menores de quince años. JE Echevarría; J Oteo (Editores). Centro Nacional de Microbiología. Programas de Vigilancia Microbiológica, ISCIII; 2021-2022. Disponible en: https://repisalud.isciii.es/entities/publication/06825c9d-903f-48b8-ac7e-a2b1791d7b48

Programa de vigilancia de Enterovirus y de Parálisis Fláccida en menores de quince años. Centro Nacional de Microbiología. Instituto de Salud Carlos III. Disponible en: https://repisalud.isciii.es/entities/publication/cf9a0ee7-499f-4eaa-9fc9-20ff1da7e0dd

Melnick JL, Schmidt NJ, Hampil B, Ho HH. Lyophilized combination pools of enterovirus equine antisera: preparation and test procedures for the identification of field strains of 19 group A coxsackievirus serotypes. Intervirology. 1977;8(3):172-181.

González-Sanz R, Taravillo I, Reina J, Navascués A, Moreno-Docón A, Aranzamendi M et al. Enterovirus D68-associated respiratory and neurological illness in Spain, 2014–2018. Emerg Microbes Infect. 2019. 8(1):1438-1444.

Cabrerizo M, Echevarria JE, Gonzalez I, de Miguel T, Trallero G. Molecular epidemiological study of HEV-B enteroviruses involved in the increase in meningitis cases occurred in Spain during 2006. J Med Virol [Internet]. 2008/04/23. 2008;80(6):1018-1024.

Global Polio Laboratory Network. Updates on ITD molecular assays and testing algorithm. August 9th 2016. Disponible en: https://polioeradication.org/wp-content/uploads/2024/05/GP2-Updates-on-ITD-molecular-testing.pdf

Gerloff N, Sun H, Mandelbaum M, Maher C, Nix WA, Zaidi S et al. Diagnostic assay development for poliovirus eradication. J Clin Microbiol. 2018. 56(2):e01624-01617.

Dunn G, Klapsa D, Wilton T, Stone L, Minor PD, Martin J. Twenty-Eight Years of Poliovirus Replication in an Immunodeficient Individual: Impact on the Global Polio Eradication Initiative. PLOS Pathog [Internet]. 2015 Aug 1 [consultado 7 feb 2025];11(8):e1005114.

WHO Guidelines for environmental surveillance of poliovirus circulation. 2003. Disponible en: https://polioeradication.org/wp-content/uploads/2016/07/WHO_V-B_03.03_eng.pdf

Hjelmsø MH, Hellmér M, Fernandez-Cassi X, Timoneda N, Lukjancenko O, Seidel M et al. Evaluation of Methods for the Concentration and Extraction of Viruses from Sewage in the Context of Metagenomic Sequencing. PLoS One [Internet]. 2017 Jan 1 [consultado 3 dic 2024];12(1).

Trallero G, Avellón A, Otero A, De Miguel T, Alonso M, Pérez-Breña P. Red de Laboratorios del Plan de Erradicación de la Poliomielitis (1998-2003): 6 años de vigilancia de parálisis flácida aguda en España. Enferm Infecc Microbiol Clin [Internet]. 2006 Mar 1 [consultado 3 dic 2024];24(3):167-172.

Trallero G, Cabrerizo M, Avellón A. Papel del Laboratorio Nacional de Poliovirus en el Programa de erradicación y vigilancia de la poliomielitis. Rev Esp Salud Publica [Internet]. 2013 Sep [consultado 3 dic 2024];87(5):471-479.

Avellón A, Trallero G, Merino B et al. y responsables del Plan de Contención de Poliovirus salvaje en los laboratorios españoles. Erradicación de la poliomielitis. Búsqueda y control de poliovirus salvajes almacenados en los laboratorios españoles. [Internet]. [Consultado 3 dic 2024]. Disponible en: https://www.elsevier.es/es-revista-enfermedades-infecciosas-microbiologia-clinica-28-pdf-S0213005X04730384

Avellón A, Cabrerizo M, De Miguel T, Pérez-Breña P, Tenorio A, Pérez JL et al. Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain. Emerging Infectious Diseases. 2008. 14(11):1807–1809.

Ministerio de Sanidad, Centro de Coordinación de Alertas y Emergencias Sanitarias (CCAES). Evaluación rápida de riesgo. Riesgo asociado a la importación de virus de la poliomielitis en España. 2019. Disponible en: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/polio/docs/ERR_poliovirus.pdf

Fernandez-Garcia MD, Faye M, Diez-Fuertes F, Moreno-Docón A, Chirlaque-López MD, Faye O et al. Metagenomic sequencing, molecular characterization, and Bayesian phylogenetics of imported type 2 vaccine-derived poliovirus, Spain, 2021. Front Cell Infect Microbiol. 2023. 2:13:1168355.

López MDC, Cabrerizo M, Herrador BRG, Masa-Calles J, Alarcón-Linares ME, Allende A et al. An imported case of vaccine-derived poliovirus type 2, Spain in the context of the ongoing polio Public Health Emergency of International Concern, September 2021. Eurosurveillance. 2021. 26(50):2101068.

Trallero G, Casas I, Tenorio A, Echevarria JE, Castellanos A, Lozano A et al. Enteroviruses in Spain: Virological and epidemiological studies over 10 years (1988-97). Epidemiol Infect. 2000. 124(3):497-506 124(3):497-506.

Trallero G, Avellon A, Otero A, De Miguel T, Pérez C, Rabella N et al. Enteroviruses in Spain over the decade 1998-2007: Virological and epidemiological studies. J Clin Virol. 2010. 47(2):170-176.

Calderón KI, Díaz-de Cerio M, Otero A, Muñoz-Almagro C, Rabella N, Martínez-Rienda I et al. Molecular epidemiology of coxsackievirus B3 infection in Spain, 2004-2014. Arch Virol. 2016. 161(5):1365-1370.

Cabrerizo M, Díaz-Cerio M, Muñoz-Almagro C, Rabella N, Tarragó D, Romero MP et al. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain. J Med Virol. 2017. 89(3):435-442.

Cabrerizo M, Trallero G, Simmonds P. Recombination and evolutionary dynamics of human echovirus 6. J Med Virol. 2014. 86(5):857-864.

Avellón A, Rubio G, Palacios G, Casas I, Rabella N, Reina G et al. Enterovirus 75 and aseptic meningitis, Spain, 2005. Emerg Infect Dis [Internet]. 2006 [consultado 3 dic 2024];12(10):1609-1611.

Cabrerizo M, Echevarria JE, Otero A, Lucas P, Trallero G. Molecular characterization of a coxsackievirus A24 variant that caused an outbreak of acute haemorrhagic conjunctivitis in Spain, 2004. J Clin Virol. 2008. 43(3):323-327.

Martínez-López N, Muñoz-Almagro C, Launes C, Navascués A, Imaz-Pérez M, Reina J et al. Surveillance for enteroviruses associated with hand, foot, and mouth disease, and other mucocutaneous symptoms in Spain, 2006–2020. Viruses. 2021. 28;13(5):781.

Cabrerizo M, García-Iñiguez JP, Munell F, Amado A, Madurga-Revilla P, Rodrigo C et al. First Cases of Severe Flaccid Paralysis Associated with Enterovirus D68 Infection in Spain, 2015-2016. Pediatr Infect Dis J. 2017. 36(12):1214-1216.

Benschop KSM, Albert J, Anton A, Andres C, Aranzamendi M, Armannsdottir B et al. Re-emergence of enterovirus d68 in europe after easing the covid-19 lockdown, september 2021. Eurosurveillance. 2021. 26(45):2100998.

González-Sanz R, Casas-Alba D, Launes C, Muñoz-Almagro C, Montserrat Ruiz-García M, Alonso M et al. Molecular epidemiology of an enterovirus A71 outbreak associated with severe neurological disease, Spain, 2016. Eurosurveillance. 2019. 24(7):1800089.

Ministerio de Sanidad. 2º Estudio de Seroprevalencia en España. Rev Esp Salud Pública. 2021; Vol. 95: 18 de marzo e1-5; 2021. Disponible en: https://ojs.sanidad.gob.es/index.php/resp/article/view/471/714

World health organization (WHO), Vaccine-preventable disease surveillance data. Disponible en: https://www.who.int/europe/teams/vaccine-preventable-diseases-immunization/vaccine-preventable-disease-surveillance-data

Masa-Calles J, Torner N, López-Perea N, De Mier M de VT, Fernández-Martínez B, Cabrerizo M et al. Acute flaccid paralysis (AFP) surveillance: challenges and opportunities from 18 years’ experience, Spain, 1998 to 2015. Eurosurveillance. 2018. 23(47):1700423.

Link-Gelles R, Lutterloh E, Ruppert PS, Backenson PB, St. George K, Rosenberg ES et al. Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater-New York, June-August 2022. Am J Transplant [Internet]. 2022 Oct 1 [consultado 13 dic 2024];22(10):2470-2474.

Klapsa D, Wilton T, Zealand A, Bujaki E, Saxentoff E, Troman C et al. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet (London, England) [Internet]. 2022 Oct 29 [consultado 13 dic 2024];400(10362):1531-1538.

Böttcher S, Kreibich J, Wilton T, Saliba V, Blomqvist S, Al-Hello H et al. Detection of circulating vaccine-derived poliovirus type 2 (cVDPV2) in wastewater samples: a wake-up call, Finland, Germany, Poland, Spain, the United Kingdom, 2024. Eurosurveillance [Internet]. 2025 Jan 23 [consultado 7 feb 2025];30(3):2500037.

Rendi-Wagner P, Kluge H. Poliovirus detections in Europe–urgent action needed to keep Europe polio-free. Eurosurveillance [Internet]. 2025 Jan 30 [consultado 7 feb 2025];30(4):2500076.

Published

2025-03-21

How to Cite

1.
Cabrerizo M, Fernández-García MD. The role of the National Polio Laboratory and the network of Sub-National Laboratories in the eradication of poliomyelitis in Spain: e202503016. Rev Esp Salud Pública [Internet]. 2025 Mar. 21 [cited 2026 Apr. 1];99(1):15 páginas. Available from: https://ojs.sanidad.gob.es/index.php/resp/article/view/1024

Issue

Section

Colaboraciones especiales

Categories